ASCO 2023 Breast Cancer Highlights with Prof Michael Gnant

Поделиться
HTML-код
  • Опубликовано: 5 сен 2024
  • Free MedAll Certification - Fill in the 1 minute feedback form to get a certificate of learning for your CV:
    app.medall.org...
    Professor Gnant from the Medical University of Vienna talks to Dr Phil McElnay to summarize the latest advances and trials in Breast Cancer from ASCO 2023 (the annual meeting of the American Society of Clinical Oncology), including:
    • The NATALEE trial exploring CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer
    • Innovation in endocrine therapy for hormone receptor-positive breast cancer
    • Challenges of affordability for individualized treatment selection
    About Professor Gnant
    Professor Gnant is a renowned professor of surgery specializing in surgical oncology, with a particular focus on breast cancer. In addition to his clinical practice, he is a Professor of Surgery at the Medical University of Vienna, Austria and President of the Austrian Breast and Colorectal Cancer Study Group. Professor Gnant’s research primarily focusses on endocrine treatment in early breast cancer. He is also actively engaged in neoadjuvant trials.
    About MedAll
    MedAll is the fastest growing community of medical professionals and students. Alongside thousands of incredible healthcare organisations and individuals from institutions like Harvard Medical School, Johns Hopkins & Baylor Medical School, we have built an amazing resource of free online medical teaching sessions, conferences and on demand videos that can be accessed anytime:
    • Track your CME/CPD
    • Learn from the best educators
    • Build your CV with certificates of learning
    • Prepare for exams, interviews & assessments
    We are on a mission to help train millions more healthcare workers by increasing access to great training, reducing travel barriers, providing flexibility around parental or other caring responsibilities and by offering alternative ways to study to support neurodiversity.
    Together, we have the power to make change, join us!
    www.medall.org

Комментарии •